Archive | Avodart RSS feed for this section

Avodart prostate cancer lawsuit

8. April 2014


The FDA has issued a warning of an increased risk of high-grade prostate cancer with Avodart (generic:dutasteride), currently approved to treat benign adenofibromyomatous hyperplasia or BPH. This risk appears to be low, but healthcare professionals should be aware of this safety information, and weigh the known benefits against the potential risks when deciding to start […]

Continue reading...